Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2023 Earnings Call Transcript

Eric Coldwell: That’s actually somewhat reassuring and good, I think. Last question. We have seen a number of companies this quarter that we find out, maybe somewhat after the fact that OpEx looked a little high in the quarter, and we got some pick up below the line. We weren’t quite sure why. I wouldn’t call it a big notable item at Medpace this quarter but I am curious if you had any unusual items running through the P&L or abnormally large changes in the P&L due to things like deferred compensation adjustments or anything else? That will be my last one. Thank you.

Kevin Brady: Yeah, Eric, nothing on deferred compensation. We don’t have a deferred comp program. The stuff that for us that’s sitting in kind of miscellaneous income, it’s primarily going to be foreign exchange or VAT. And we do have some investments that roll through there as well. And the volatility is typically caused by FX but nothing specific to call out in that particular area, just kind of the normal fluctuations that we see in those three buckets quarter-to-quarter.

Eric Coldwell: All right, well good stuff. Great job, thanks guys.

August Troendle: Thanks, Eric.

Operator: Thank you. This concludes today’s conference call. I would now like to turn it back to Lauren Morris for closing remarks.

Lauren Morris: Thank you for joining us on today’s call and for your interest in Medpace. We look forward to speaking with you again on our first quarter 2024 earnings call.

Operator: Thank you for participating. You may now disconnect.